Researchers at the University of Illinois at Chicago have released promising results from a phase I/II clinical trial for a new enzyme-based treatment for severe dry eye.The trial compared eye drops
A phase I clinical trial in Italy has shown recombinant human nerve growth factor (rhNGF) to be a potential treatment for dry eye disease (DED).A total of 40 patients with moderate to severe,
Dry eye symptoms and photophobia improved in patients suffering chronic migraine when treated with botulinum toxin A (BoNT-A) injections.The study of 76 patients at Miami Veterans Affairs Medical
This is a randomised, prospective intervention study that evaluated the effectiveness of platelet-rich plasma (PRP) injections in the treatment of severe, aqueous-deficient dry eye. PRP is a blood derivative that has previously been successfully used to treat ocular surface disorders such as persist
Blepharitis is an epidemic – defined as inflammation affecting the eyelashes, eyelids and the ocular surface, it is widely recognised as one of the most common ocular conditions.
Re:Vision’s new Co-Management Conference on Sunday 11 August to be held at its surgery in Mt Wellington, Auckland, promises to be the first of its kind in New Zealand, said organisers.
A trial using recombinant human nerve growth factor (rhNGF) eye drops to treat dry eye disease has had promising results.
Breakthroughs in healthcare can come from unusual places, said Assistant Professor Jianzhong Chen, and he and his colleagues may have discovered a new one for dry eye.
Extended screen time is reducing the normal blink rate by 60%, contributing to dry eye syndrome, a doctor has said following office workers reporting concerns over screen time-related health issues. A
The University of Auckland’s 2019 Excellence in Ophthalmology and Vision Research awards evening was planned as a special night marking 20 years since the awards began and the rise and rise of ophthalmology and vision research in New Zealand.
NVision Eyecare has opened for business in Albany on Auckland’s North Shore. Specialising in myopia control, rigid gas permeable (RGP) lens fitting and dry eye management, the practice is focusing on speciality eye care, and is the first to offer LipiFlow thermal pulsation to treat meibomian gland d
